Meritxell Sabidó

Associate Director Epidemiology
The healthcare business of Merck KGaA, Darmstadt, Germany, Germany

Poster(s):

• (C-184) Post-approval pregnancy safety evidence for signal identification: Comparison of preliminary results from two methodological approaches for high-efficacy drugs contraindicated during pregnancy
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-118) Standardization of CLARION study-specific data using a common data model: Experience from multiple sclerosis registries and data sources
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET